Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.Some side effects may not be reported.
It contains clindamycin hydrochloride 1% (active ingredient), ethanol, dioctyl malate and purified water. You may report them to the The easiest way to lookup drug information, identify pills, check interactions and set up your own personal medication records. Available for Android and iOS devices. Other reported clinical experience has not identified differences in responses between the elderly and younger patients.Cases of diarrhea, bloody diarrhea and colitis (including pseudomembranous colitis) have been reported as adverse reactions in patients treated with oral and parenteral formulations of clindamycin and rarely with topical clindamycin (see WARNINGS).Abdominal pain, gastrointestinal disturbances, gram-negative folliculitis, eye pain and contact dermatitis have also been reported in association with the use of topical formulations of clindamycin.Keep all liquid dosage forms in containers tightly closed.Store at 20°C to 25°C (68°F to 77°F) [See USP Controlled Room Temperature].The easiest way to lookup drug information, identify pills, check interactions and set up your own personal medication records. Clindamycin has the potential to cause adverse effects on the breast-fed infant's gastrointestinal flora. Diarrhea, bloody diarrhea, and colitis (including pseudomembranous colitis) have been reported with the use of topical and systemic clindamycin.Studies indicate a toxin(s) produced by clostridia is one primary cause of antibiotic-associated colitis. 3.


Monitor the breast-fed infant for possible adverse effects on the gastrointestinal flora, such as diarrhea, candidiasis (thrush, diaper rash) or rarely, blood in the stool indicating possible antibiotic-associated colitis.The developmental and health benefits of breastfeeding should be considered along with the mother's clinical need for clindamycin and any potential adverse effects on the breast-fed child from clindamycin or from the underlying maternal condition.If used during lactation and clindamycin phosphate topical solution is applied to the chest, care should be taken to avoid accidental ingestion by the infant.Safety and effectiveness in pediatric patients under the age of 12 have not been established.Clinical studies for Clindamycin Phosphate did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subjects. Use of the topical formulation of clindamycin results in absorption of the antibiotic from the skin surface. Cleocin T (clindamycin)." Connetics Inc, Palo Alto, CA.

In the event of accidental contact with sensitive surfaces (eye, abraded skin, mucous membranes), bathe with copious amounts of cool tap water. Clindamycin phosphate is a water soluble ester of the semi-synthetic antibiotic produced by a 7(S)- chloro-substitution of the 7(R)-hydroxyl group of the parent antibiotic lincomycin. There are no adequate studies in pregnant women during the first trimester of pregnancy. The colitis is usually characterized by severe persistent diarrhea and severe abdominal cramps and may be associated with the passage of blood and mucus. Applies to clindamycin topical: vaginal cream, vaginal suppository. Along with its needed effects, clindamycin topical may cause some unwanted effects. Orally and parenterally administered clindamycin has been associated with severe colitis which may result in patient death. During this period of time, Abnormal labor occurred in 1.1% of pregnant patients (in their second trimester) compared to 0% of patients given placebo for 7 days.Fungal infections occurred in 1.7% of pregnant patients (in their second trimester) compared to 0% of patients given placebo for 7 days.1. Clindamycin phosphate topical solution USP, 1% contains clindamycin phosphate, USP, at a concentration equivalent to 10 mg clindamycin per milliliter. Vancomycin has been found to be effective in the treatment of antibiotic-associated pseudomembranous colitis produced by Cholestyramine or colestipol resins bind vancomycin Diarrhea, colitis, and pseudomembranous colitis have been observed to begin up to several weeks following cessation of oral and parenteral therapy with clindamycin.Call your doctor for medical advice about side effects. This medicine is a colorless, solution ‹ Back to Gallery. O 07. Cerner Multum, Inc. "UK Summary of Product Characteristics." Because the binding sites for these antibacterial drugs overlap, cross resistance is sometimes observed among lincosamides, macrolides and streptogramin B. Macrolideinducible resistance to clindamycin occurs in some isolates of macrolide-resistant bacteria.Clindamycin phosphate topical solution contains an alcohol base which will cause burning and irritation of the eye.

You may report side effects to Viona Pharmaceuticals Inc. at 1-888-304-5011 or FDA at 1-800-FDA-1088.We comply with the HONcode standard for trustworthy health information - Evoclin (clindamycin topical)."

Cleocin Vaginal Ovules (clindamycin topical)" Pharmacia and Upjohn, Kalamazoo, MI. "Product Information. color colorless shape No data. Clindamycin Phosphate Topical Solution, USP 1% contains clindamycin phosphate, USP, at a concentration equivalent to 10 mg clindamycin per milliliter. When significant diarrhea occurs, the drug should be discontinued.